United States

People: Roche Holding AG (RHHVF.PK)

RHHVF.PK on OTC Markets Group

18 Aug 2017
Change (% chg)

$-5.20 (-2.05%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Schwan, Severin 

Dr. Severin Schwan has been Chairman of the Corporate Executive Committee, Chief Executive Officer and Executive Director of Roche Holding Ltd since 2013. He was Chairman of the Corporate Executive Committee and Chief Executive Officer of Roche Holding AG from March 4, 2008. He was previously Chief Executive Officer of the Division Roche Diagnostics and Member of the Corporate Executive Committee at the Company from January 1, 2006. Between 1993 and 1995, he was a Trainee at Corporate Finance for Roche Basel. From 1995 until 1998, he was Head of Finance & Administration at Roche Brussels. From 1998 until 2000, Dr. Schwan was Head Finance & Informatics at Roche Grenzach, Germany and Member of the Executive Board of Roche Deutschland Holding GmbH. From 2000 until 2004, he was Head of Global Finance & Services at Roche Diagnostics, Basel. Since 2009, Dr. Schwan has been Member of the Board of Directors of Chugai Pharmaceuticals, Japan, and Member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC). Dr. Schwan studied Economics at Universitaet Innsbruck, University of York and University of Oxford. He gained an Economics Degree from Innsbruck. He studied Law at Universitaet Innsbruck and gained a Law degree in 1991. Dr. Schwan then completed a Doctorate in Law at Universitaet Innsbruck in 1993 and Research studies at Universite Catholiques de Louvaine, Belgium.

Basic Compensation

Total Annual Compensation, CHF 6,891,960
Restricted Stock Awards, CHF --
Long-Term Incentive Plans, CHF --
All Other, CHF 4,750,500
Fiscal Year Total, CHF 11,642,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --